In the last quarter the FDA gave the nod to 10 digital health devices. Innovations that aimed to help diabetes management were popular, ranging from the first integrated continuous glucose monitor, which was put out by Dexcom, to Glooko’s insulin titration tool.
Not all FDA news this quarter was good news. In February Roche’s Accu-Check Connect Diabetes Management App was recalled by the FDA for...
Yesterday Dexcom got the nod from the FDA to market their Dexcom G6, an integrated continuous glucose monitoring system (iCGM), making it the first interoperable CGM to get the designation.
“We are a company of firsts, almost everything that has been done in our industry has been done by us first,” Dexcom CEO Kevin Sayer told MobiHealthNews, citing that Dexcom was the first company to have a...
Last week, Fitbit announced that it was acquiring Twine Health for an undisclosed sum. The news came as a surprise to many who still think of Fitbit as primarily a consumer-facing wearable device company. But an increasingly large slice of Fitbit is Fitbit Health Solutions, the company’s employee wellness business. And for Fitbit Health Solutions, Twine Health — which itself pivoted toward the...
UnitedHealthcare and Dexcom announced today at CES in Las Vegas that they will collaborate on a pilot program to provide Dexcom CGMs to UnitedHealthcare Medicare Advantage plan participants.
“With more than 27 million people nationwide living with Type 2 diabetes there is urgent need to address this epidemic in new ways,” Brian Thompson, CEO of UnitedHealthcare Medicare and retirement, said in a...
When Fitbit announced, after months of hints and rumors, that it was launching a smartwatch, it seemed likely that the answer to one big question would determine whether the health and fitness company could succeed: Could Fitbit build an app store to compete with the Apple Watch's?
Now, the app store in question, Fitbit's App Gallery, is finally starting to take shape. Fitbit announced today that...
Now that the Abbott Freestyle Libre has received FDA clearance, Abbott and Dexcom will be forced into tight competition in the US market. On Dexcom’s third quarter call, CEO Kevin Sayer spent some time assuaging investor fears about that friction.
“Late in the third quarter, the FDA approved Abbott's FreeStyle Libre flash glucose monitoring system,” Sayer said on the call. “We always believed the...
All of the diverse operations of Verily, the life sciences technology company that began its life as Google X Life Sciences, can be summed up with a simple sentence: We should be treating our bodies at least as well as we treat our cars.
At the Health 2.0 Fall Conference in Santa Clara this week, Verily Chief Technology Officer Brian Otis spoke with Health 2.0 cofounder and CEO Dr. Indu Subaya on...
Continuous glucose monitoring company Dexcom, which already allows users to monitor their CGM data on their phones and Apple Watch, is now making some patient data available to third parties via an API.
"If you look back at the past when our hardware was all proprietary, we’ve evolved from that to an app company where our CGM now works as an app on the phone," Dexcom CEO Kevin Sayer told...
Good news for anyone who thought Fitbit's move toward the smartwatch market would be a move away from health: The wearable maker has just announced a partnership with Dexcom that will bring data from the company's continuous glucose monitor directly to the display of Fitbit's upcoming Ionic smartwatch.
Athough Fitbit's have been used in the management of chronic diseases in a number of hospital...
A new study published today in Annals of Internal Medicine and sponsored by Dexcom shows that a continuous glucose monitor could lower the HbA1c scores of people with Type 2 diabetes, and that acceptance of the technology is high among that group as well.
Right now, continuous glucose monitoring is a technology mostly used by people with Type 1 diabetes, many of whom administer insulin via an...
